SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 6th, 2017 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 15, 2017, between Hancock Jaffe Laboratories, Inc., a Delaware corporation company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
STANDARD INDUSTRIAL/COMMERCIAL SINGLE-TENANT LEASE - NET (DO NOT USE THIS FORM FOR MULTI-TENANT BUILDINGS)Hancock Jaffe Laboratories, Inc. • November 6th, 2017 • Surgical & medical instruments & apparatus
HANCOCK JAFFE LABORATORIES, INC. MEDICAL ADVISORY BOARD AGREEMENTMedical Advisory Board Agreement • November 6th, 2017 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus • California
THIS MEDICAL ADVISORY BOARD AGREEMENT (the “Agreement”) is made as of October 1, 2016 by and between Hancock Jaffe Laboratories Inc., a Delaware corporation (“HJL”), located at 70 Doppler, Irvine, California, 92618 and Afksendyios Kalangos, M.D.
Development and Manufacturing AgreementDevelopment and Manufacturing Agreement • November 6th, 2017 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus
This Development and Manufacturing Agreement (the “Agreement”) is made and entered into on this 1st day of February, 2013, by and between Hancock Jaffe Laboratories Aesthetics, Inc. (“HJLA”), a Delaware corporation having a business address at 70 Doppler, Irvine, California and Hancock Jaffe Laboratories, Inc. (the “Company”), a Delaware corporation.
FIRST AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • November 6th, 2017 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus • California
This First Amendment to Employment Agreement (this “Amendment”), dated as of June 1, 2017 (the “Effective Date”), is made by and between Hancock Jaffe Laboratories, Inc., a Delaware corporation (“Hancock Jaffe”) and William Abbott (“Employee,” and together with Hancock Jaffe, the “Parties”), and amends that certain Employment Agreement, dated as of July 1, 2016, by and between Hancock Jaffe and Employee (the “Employment Agreement”).
Asset Purchase AgreementAsset Purchase Agreement • November 6th, 2017 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus • Massachusetts
This Asset Purchase Agreement is dated March 18, 2016 (“Agreement”) and is by and between LeMaitre Vascular, Inc. with offices at 63 Second Avenue, Burlington, MA 01803 (“LMAT”) and Hancock Jaffe Laboratories, Inc. with offices at 70 Doppler, Irvine, CA 92618 (“HJL” and together with LMAT, the “Parties”).
AMENDMENT No. 5 TO LOAN AGREEMENTLoan Agreement • November 6th, 2017 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus
This Amendment to Loan Agreement DRICBDH0615 (the “Amendment”) is made and entered into as of June 26, 2017, by and between Biodyne Holding SA, a Swiss corporation (the “Lender”) and Hancock Jaffe Laboratories, Inc., a Delaware corporation, (the “Borrower”).
LOAN AGREEMENT DRICBDH0615Loan Agreement • November 6th, 2017 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus • Vaud
BYODINE HOLDING SA, a company incorporated under the laws of SWITZERLAND and whose registered office is situated at c/o GRF Fiduciaire SA, Rue de la Gare13, 1110 Morges, Switzerland (hereunder referred to as “the Lender”).
Services and Material Supply AgreementServices and Material Supply Agreement • November 6th, 2017 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus • California
This Services and Material Supply Agreement (the “Agreement”) is made and entered into effective March 4, 2016 by and between Hancock Jaffe Laboratories, Inc. (“Client”), a Delaware corporation having a business address at 70 Doppler, Irvine, California, 92618, and ATSCO, Inc. (“Supplier”); a Nevada corporation, having a business address at 3117 Kingston Drive, Plano, Texas, 75074.
Post-Acquisition Supply AgreementSupply Agreement • November 6th, 2017 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus • Massachusetts
This Post-Acquisition Supply Agreement (the “Supply Agreement”) made and entered into effective as of March 18, 2016 (the “Effective Date”), is between Hancock Jaffe Laboratories, Inc., a Delaware corporation(“HJL”), with its address at 70 Doppler, Irvine, California 92618, and LeMaitre Vascular, Inc., a Delaware corporation(“LMAT”), with an address at 63 Second Avenue, Burlington, Massachusetts 01803 (hereinafter sometimes individually or collectively referred to as a “Party” or the “Parties,” respectively) . All capitalized terms not defined herein shall have the meanings ascribed to them in the Asset Purchase Agreement (defined hereinafter).
SECOND AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • November 6th, 2017 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus • California
This Second Amendment to Employment Agreement (this “Amendment”), dated as of June 12, 2017 (the “Effective Date”), is made by and between Hancock Jaffe Laboratories, Inc., a Delaware corporation (“Hancock Jaffe”) and Steven Cantor (“Employee” and/or “Executive”) and together with Hancock Jaffe, (the “Parties”), and amends that certain Employment Agreement, dated as of July 1, 2016, by and between Hancock Jaffe and Employee (the “7/1/2016 Employment Agreement”), as amended by the First Amendment to Employment Agreement by and between the Parties, dated as of December 2, 2016, (the “First Amendment”, and together with the 7/1/2016 Employment Agreement, collectively, the “Employment Agreement”).
AMENDMENT No. 4 TO LOAN AGREEMENTLoan Agreement • November 6th, 2017 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus
This Amendment to Loan Agreement DRICBDH0615 (the “Amendment”) is made and entered into as of March 27, 2017, by and between Biodyne Holding SA, a Swiss corporation (the “Lender”) and Hancock Jaffe Laboratories, Inc., a Delaware corporation, (the “Borrower”).
